Yoo Hong Min

Yonsei University — South Korea

Medicine · Health Sciences

38h-index5.4kcitations422works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(116), Lymphoma Diagnosis and Treatment(42), Hematopoietic Stem Cell Transplantation(41), Photonic and Optical Devices(33), Advanced Fiber Laser Technologies(33)

Publications422 total

CRISPR/Cas12a with Antisense Oligonucleotide-Regulated Translational Amplification for Ultrasensitive Nucleic Acid Detection
ACS Sensors·2025
Methyltransferase Detection Based on Target-Responsive Transcription Amplification of Light-Up Aptamer
Analytical Chemistry·2025
Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia
Cells·2025Open Access
Split Probe-Induced Protein Translational Amplification for Nucleic Acid Detection
ACS Applied Bio Materials·2024
Revisiting ELISA with in situ amplification of biomarkers to boost its sensitivity
Sensors and Actuators B Chemical·2024· 15 cited
Small Molecule Detection with Ligation-Dependent Light-Up Aptamer Transcriptional Amplification
ACS Applied Bio Materials·2024· 4 cited
CRISPR/Cas12a Collateral Cleavage-Driven Transcription Amplification for Direct Nucleic Acid Detection
Analytical Chemistry·2024· 5 cited
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Blood Advances·2023· 21 citedOpen Access
Changing the strategic paradigm for the treatment of adult acute myeloid leukemia
Journal of Korean Medical Association·2023· 1 citedOpen Access
Supplementary Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
2023Open Access
Supplemental Table 2 from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Supplementary Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
2023Open Access
Data from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Supplemental Table 1 from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Supplemental Table 2 from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
2023Open Access
Supplementary Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
2023Open Access
Supplementary Figures S1-S5 and Legends from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Supplemental Table 1 from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
2023Open Access
Supplementary Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
2023Open Access
page 1 of 22Next →

Frequent Co-authors

June‐Won Cheong(33), Jin Seok Kim(21), Jee Sook Hahn(9), Seung‐Tae Lee(9), Ji Eun Jang(9), Yu Ri Kim(9), Yun Woong Ko(8), Soo‐Jeong Kim(8), Hoyoung Maeng(6), Ju In Eom(6), Haerim Chung(5), Hoi-Kyung Jeung(4), Jung Yeon Lee(4), Mark Hong Lee(4), Sang Kyun Sohn(4), Soo‐Mee Bang(4), Chul Won Jung(4), Deog‐Yeon Jo(4), Jae Hoon Lee(4), Hyunsoo Cho(4)